{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T04:10:48Z","timestamp":1778299848557,"version":"3.51.4"},"reference-count":23,"publisher":"Japan Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1507\/endocrj.ej25-0431","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T22:08:13Z","timestamp":1769465293000},"page":"597-605","source":"Crossref","is-referenced-by-count":0,"title":["Use, efficacy, and safety of desmopressin for congenital nephrogenic diabetes insipidus in children: a nationwide survey"],"prefix":"10.1507","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7053-7004","authenticated-orcid":false,"given":"Kento","family":"Ikegawa","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, Tokyo Metropolitan Children\u2019s Medical Center, Tokyo, Japan"},{"name":"Clinical Research Support Center, Tokyo Metropolitan Children\u2019s Medical Center, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8604-7517","authenticated-orcid":false,"given":"Masanobu","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Division of Pediatrics and Perinatology, Faculty of Medicine, Tottori University, Tottori, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Aoyama","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Neonatology, Nagoya City University Graduate School of Medical Sciences, Aichi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Graduate School of Medicine, The University of Osaka, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuo","family":"Kubota","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Graduate School of Medicine, The University of Osaka, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Nagasaki","sequence":"additional","affiliation":[{"name":"Division of Pediatrics, Department of Homeostatic Regulation and Development, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Setsuko","family":"Naganuma","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kumamoto Rosai Hospital, Kumamoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Ono","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Chiba Kaihin Municipal Hospital, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Higuchi","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology, Metabolism, and Nephrology, Osaka City General Hospital, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruo","family":"Mizuno","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Fujita Health University School of Medicine, Aichi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Kanzaki","sequence":"additional","affiliation":[{"name":"Asahigawaso Rehabilitation and Medical Center, Okayama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Morikawa","sequence":"additional","affiliation":[{"name":"Clinical Research Support Center, Tokyo Metropolitan Children\u2019s Medical Center, Tokyo, Japan"},{"name":"Research Promotion Center, Tokyo Metropolitan Hospital Organization, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Honda","sequence":"additional","affiliation":[{"name":"Clinical Research Support Center, Tokyo Metropolitan Children\u2019s Medical Center, Tokyo, Japan"},{"name":"Research Promotion Center, Tokyo Metropolitan Hospital Organization, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Amano","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Tokyo Metropolitan Children\u2019s Medical Center, Tokyo, Japan"},{"name":"Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Tokyo Metropolitan Children\u2019s Medical Center, Tokyo, Japan"},{"name":"Department of Pediatrics, Tama-Hokubu Medical Center, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Levtchenko E, Ariceta G, Arguedas Flores O, Bichet DG, Bockenhauer D, et al. (2025) International expert consensus statement on the diagnosis and management of congenital nephrogenic diabetes insipidus (arginine vasopressin resistance). Nat Rev Nephrol 21: 83\u201396.","DOI":"10.1038\/s41581-024-00897-z"},{"key":"2","unstructured":"2 Fujimoto M, Okada S, Kawashima Y, Nishimura R, Miyahara N, et al. (2014) Clinical overview of nephrogenic diabetes insipidus based on a nationwide survey in Japan. Yonago Acta Med 57: 85\u201391."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Moeller HB, Rittig S, Fenton RA (2013) Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment. Endocr Rev 34: 278\u2013301.","DOI":"10.1210\/er.2012-1044"},{"key":"4","doi-asserted-by":"crossref","unstructured":"5 Kavanagh C, Uy NS (2019) Nephrogenic diabetes insipidus. Pediatr Clin North Am 66: 227\u2013234.","DOI":"10.1016\/j.pcl.2018.09.006"},{"key":"5","doi-asserted-by":"crossref","unstructured":"6 D\u2019Alessandri-Silva C, Carpenter M, Ayoob R, Barcia J, Chishti A, et al. (2019) Diagnosis, treatment, and outcomes in children with congenital nephrogenic diabetes insipidus: a pediatric nephrology research consortium study. Front Pediatr 7: 550.","DOI":"10.3389\/fped.2019.00550"},{"key":"6","doi-asserted-by":"crossref","unstructured":"7 Milano S, Carmosino M, Gerbino A, Svelto M, Procino G (2017) Hereditary nephrogenic diabetes insipidus: pathophysiology and possible treatment. An Update. Int J Mol Sci 18: 2385.","DOI":"10.3390\/ijms18112385"},{"key":"7","doi-asserted-by":"crossref","unstructured":"8 Schernthaner-Reiter MH, Adams D, Trivellin G, Ramnitz MS, Raygada M, et al. (2016) A novel AVPR2 splice site mutation leads to partial X-linked nephrogenic diabetes insipidus in two brothers. Eur J Pediatr 175: 727\u2013733.","DOI":"10.1007\/s00431-015-2684-4"},{"key":"8","doi-asserted-by":"crossref","unstructured":"9 Sahakitrungruang T, Tee MK, Rattanachartnarong N, Shotelersuk V, Suphapeetiporn K, et al. (2010) Functional characterization of vasopressin receptor 2 mutations causing partial and complete congenital nephrogenic diabetes insipidus in Thai families. Horm Res Paediatr 73: 349\u2013354.","DOI":"10.1159\/000308167"},{"key":"9","doi-asserted-by":"publisher","unstructured":"10 Neocleous V, Skordis N, Shammas C, Efstathiou E, Mastroyiannopoulos NP, et al. (2012) Identification and characterization of a novel X-linked AVPR2 mutation causing partial nephrogenic diabetes insipidus: a case report and review of the literature. Metabolism 61: 922\u2013930.","DOI":"10.1016\/j.metabol.2012.01.005"},{"key":"10","doi-asserted-by":"crossref","unstructured":"11 Zhang M, Yu Q, Chen C, Han J, Cheng B, et al. (2019) A novel AVPR2 missense mutation in an Asian family with inherited nephrogenic diabetes insipidus: a case report. Medicine (Baltimore) 98: e15348.","DOI":"10.1097\/MD.0000000000015348"},{"key":"11","doi-asserted-by":"crossref","unstructured":"12 Bockenhauer D, Carpentier E, Rochdi D, van\u2019t Hoff W, Breton B, et al. (2010) Vasopressin type 2 receptor V88M mutation: molecular basis of partial and complete nephrogenic diabetes insipidus. Nephron Physiol 114: p. 1\u201310.","DOI":"10.1159\/000245059"},{"key":"12","doi-asserted-by":"crossref","unstructured":"13 Mizuno H, Fujimoto S, Sugiyama Y, Kobayashi M, Ohro Y, et al. (2003) Successful treatment of partial nephrogenic diabetes insipidus with thiazide and desmopressin. Horm Res 59: 297\u2013300.","DOI":"10.1159\/000070629"},{"key":"13","doi-asserted-by":"crossref","unstructured":"14 Ikegawa K, Hachiya R, Akiba K, Hasegawa Y (2022) Oral disintegrating desmopressin tablet is effective for partial congenital nephrogenic diabetes insipidus with AVPR2 mutation: a case report. Clin Pediatr Endocrinol 31: 87\u201392.","DOI":"10.1297\/cpe.2021-0032"},{"key":"14","doi-asserted-by":"crossref","unstructured":"15 Bichet DG, Bockenhauer D (2016) Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant). Best Pract Res Clin Endocrinol Metab 30: 263\u2013276.","DOI":"10.1016\/j.beem.2016.02.010"},{"key":"15","doi-asserted-by":"crossref","unstructured":"16 Takahashi K, Makita N, Manaka K, Hisano M, Akioka Y, et al. (2012) V2 vasopressin receptor (V2R) mutations in partial nephrogenic diabetes insipidus highlight protean agonism of V2R antagonists. J Biol Chem 287: 2099\u20132106.","DOI":"10.1074\/jbc.M111.268797"},{"key":"16","doi-asserted-by":"crossref","unstructured":"17 Kuramoto R, Kise R, Kanno M, Kawakami K, Ikuta T, et al. (2024) Therapeutic potentials of nonpeptidic V2R agonists for partial cNDI-causing V2R mutants. PLoS One 19: e0303507.","DOI":"10.1371\/journal.pone.0303507"},{"key":"17","doi-asserted-by":"crossref","unstructured":"18 Faerch M, Christensen JH, Rittig S, Johansson JO, Gregersen N, et al. (2009) Diverse vasopressin V2 receptor functionality underlying partial congenital nephrogenic diabetes insipidus. Am J Physiol Renal Physiol 297: F1518\u2013F1525.","DOI":"10.1152\/ajprenal.00331.2009"},{"key":"18","doi-asserted-by":"crossref","unstructured":"19 Manning M, Balaspiri L, Moehring J, Haldar J, Sawyer WH (1976) Synthesis and some pharmacological properties of deamino(4-threonine,8-D-arginine)vasopressin and deamino(8-D-arginine)vasopressin, highly potent and specific antidiuretic peptides, and (8-D-arginine)vasopressin and deamino-arginine-vasopressin. J Med Chem 19: 842\u2013845.","DOI":"10.1021\/jm00228a023"},{"key":"19","doi-asserted-by":"publisher","unstructured":"20 Sawyer WH, Acosta M, Balaspiri L, Judd J, Manning M (1974) Structural changes in the arginine vasopressin molecule that enhance antidiuretic activity and specificity. Endocrinology 94: 1106\u20131115.","DOI":"10.1210\/endo-94-4-1106"},{"key":"20","doi-asserted-by":"crossref","unstructured":"21 Arima H, Oiso Y, Juul KV, N\u00f8rgaard JP (2013) Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study. Endocr J 60: 1085\u20131094.","DOI":"10.1507\/endocrj.EJ13-0165"},{"key":"21","unstructured":"22 Eller N, Kollenz CJ, Bauer P, Hitzenberger G (1998) The duration of antidiuretic response of two desmopressin nasal sprays. Int J Clin Pharmacol Ther 36: 494\u2013500."},{"key":"22","doi-asserted-by":"crossref","unstructured":"23 Yuksel OH, Kivrak M, Sahin A, Akan S, Urkmez A, et al. (2015) A case of idiopathic diabetes insipidus presented with bilateral hydroureteronephrosis and neurogenic bladder: a pediatric case report and literature review. Can Urol Assoc J 9: E817\u2013E820.","DOI":"10.5489\/cuaj.3092"},{"key":"23","doi-asserted-by":"crossref","unstructured":"24 Faerch M, Christensen JH, Corydon TJ, Kamperis K, de Zegher F, et al. (2008) Partial nephrogenic diabetes insipidus caused by a novel mutation in the AVPR2 gene. Clin Endocrinol (Oxf) 68: 395\u2013403.","DOI":"10.1111\/j.1365-2265.2007.03054.x"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/5\/73_EJ25-0431\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T03:22:36Z","timestamp":1778296956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/5\/73_EJ25-0431\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej25-0431","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"EJ25-0431"}}